DK1217001T3 - Quinuclidinforbindelser og lægemidler indeholdende dem som den aktive bestanddel - Google Patents
Quinuclidinforbindelser og lægemidler indeholdende dem som den aktive bestanddelInfo
- Publication number
- DK1217001T3 DK1217001T3 DK00962889T DK00962889T DK1217001T3 DK 1217001 T3 DK1217001 T3 DK 1217001T3 DK 00962889 T DK00962889 T DK 00962889T DK 00962889 T DK00962889 T DK 00962889T DK 1217001 T3 DK1217001 T3 DK 1217001T3
- Authority
- DK
- Denmark
- Prior art keywords
- optionally substituted
- chain
- substituted
- denotes
- represented
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27390599 | 1999-09-28 | ||
JP2000179352 | 2000-06-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1217001T3 true DK1217001T3 (da) | 2006-03-20 |
Family
ID=26550809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00962889T DK1217001T3 (da) | 1999-09-28 | 2000-09-27 | Quinuclidinforbindelser og lægemidler indeholdende dem som den aktive bestanddel |
Country Status (20)
Country | Link |
---|---|
US (1) | US6599917B1 (fr) |
EP (1) | EP1217001B1 (fr) |
JP (1) | JP4206212B2 (fr) |
KR (1) | KR100694687B1 (fr) |
CN (1) | CN100334085C (fr) |
AT (1) | ATE312100T1 (fr) |
AU (1) | AU782114B2 (fr) |
BR (1) | BR0014331A (fr) |
CA (1) | CA2385995C (fr) |
DE (1) | DE60024651T2 (fr) |
DK (1) | DK1217001T3 (fr) |
ES (1) | ES2252063T3 (fr) |
HU (1) | HUP0203514A3 (fr) |
IL (2) | IL148631A0 (fr) |
MX (1) | MXPA02003167A (fr) |
NO (1) | NO328218B1 (fr) |
NZ (1) | NZ517788A (fr) |
RU (1) | RU2266905C2 (fr) |
TW (1) | TWI282794B (fr) |
WO (1) | WO2001023383A1 (fr) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0010955D0 (en) * | 2000-05-05 | 2000-06-28 | Novartis Ag | Organic compounds |
US7112593B2 (en) * | 2001-03-27 | 2006-09-26 | Eisai Co., Ltd. | N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient |
EP1256573A1 (fr) | 2001-05-09 | 2002-11-13 | Eisai Co., Ltd. | Procédé de préparation de stéréoisomère d'un dérivé de pyrrolidine |
US7361668B2 (en) * | 2001-10-17 | 2008-04-22 | Ucb, S.A. | Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors |
US7361671B2 (en) * | 2001-11-15 | 2008-04-22 | The Institute For Pharmaceutical Discovery, Inc. | Substituted heteroarylalkanoic acids |
DE10225537A1 (de) * | 2002-06-10 | 2003-12-18 | Bayer Ag | N-alkylierte Thiazoliumsalze und Verfahren zu deren Herstellung |
GB0218876D0 (en) * | 2002-08-13 | 2002-09-25 | Merck Sharp & Dohme | Therapeutic agents |
WO2004029050A1 (fr) | 2002-09-25 | 2004-04-08 | Memory Pharmaceuticals Corporation | Indazoles, benzothiazoles et benzoisothiazoles, leur preparation et leurs utilisations |
DE10334724A1 (de) * | 2003-07-30 | 2005-02-24 | Bayer Healthcare Ag | N-Biarylamide |
JP4667384B2 (ja) * | 2003-10-07 | 2011-04-13 | レノビス, インコーポレイテッド | イオンチャネルリガンドとしてのアミド誘導体および薬学的組成物、ならびにこれらを使用する方法 |
CA2560741C (fr) | 2004-03-25 | 2013-08-06 | Memory Pharmaceuticals Corporation | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, et leur preparation et leurs utilisations |
US8106066B2 (en) | 2005-09-23 | 2012-01-31 | Memory Pharmaceuticals Corporation | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof |
EP2132196A1 (fr) | 2007-02-26 | 2009-12-16 | Pfizer Products Inc. | Composés hétérocycliques utiles dans le traitement de maladies et de conditions |
TW201111385A (en) | 2009-08-27 | 2011-04-01 | Biocryst Pharm Inc | Heterocyclic compounds as janus kinase inhibitors |
US8420661B2 (en) * | 2010-04-13 | 2013-04-16 | Hoffmann-La Roche Inc. | Arylethynyl derivatives |
WO2011150356A1 (fr) | 2010-05-28 | 2011-12-01 | Biocryst Pharmaceuticals, Inc. | Composés hétérocycliques en tant qu'inhibiteurs de janus kinase |
WO2013102145A1 (fr) | 2011-12-28 | 2013-07-04 | Global Blood Therapeutics, Inc. | Composés d'aldéhydes hétéroaryles substitués et leurs procédés d'utilisation dans l'accroissement de l'oxygénation tissulaire |
ES2963218T3 (es) | 2011-12-28 | 2024-03-25 | Global Blood Therapeutics Inc | Productos intermedios para obtener compuestos de benzaldehído sustituidos y métodos para su uso en el aumento de la oxigenación tisular |
WO2014060381A1 (fr) | 2012-10-18 | 2014-04-24 | Bayer Cropscience Ag | Composés hétérocycliques pour la lutte contre les nuisibles |
BR112015009751A2 (pt) | 2012-10-31 | 2017-07-11 | Bayer Cropscience Ag | novos compostos heterocíclicos como pesticidas |
US20140274961A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US20160083343A1 (en) | 2013-03-15 | 2016-03-24 | Global Blood Therapeutics, Inc | Compounds and uses thereof for the modulation of hemoglobin |
US9604999B2 (en) | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
US9802900B2 (en) | 2013-03-15 | 2017-10-31 | Global Blood Therapeutics, Inc. | Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
CN111454200A (zh) | 2013-03-15 | 2020-07-28 | 全球血液疗法股份有限公司 | 化合物及其用于调节血红蛋白的用途 |
CA2902711C (fr) | 2013-03-15 | 2021-07-06 | Global Blood Therapeutics, Inc. | Derives de pyridinyl-6-methoxy-2-hydroxybenzaldehyde substitues et compositions pharmaceutiques de ceux-ci pour utilisation dans la modulation de l'hemoglobine |
WO2014145040A1 (fr) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Composés aldéhydes substitués et leurs procédés d'utilisation pour accroître l'oxygénation tissulaire |
EA201992707A1 (ru) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
CA2916564C (fr) | 2014-02-07 | 2023-02-28 | Global Blood Therapeutics, Inc. | Polymorphes cristallins de la base libre de 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
MA41841A (fr) | 2015-03-30 | 2018-02-06 | Global Blood Therapeutics Inc | Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs |
CR20170536A (es) | 2015-06-03 | 2018-02-01 | Hoffmann La Roche | Derivados de etinilo |
SG10201912511WA (en) | 2015-12-04 | 2020-02-27 | Global Blood Therapeutics Inc | Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
TWI663160B (zh) | 2016-05-12 | 2019-06-21 | 全球血液治療公司 | 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法 |
TWI778983B (zh) | 2016-10-12 | 2022-10-01 | 美商全球血液治療公司 | 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑 |
MX2021003158A (es) | 2018-09-18 | 2021-07-16 | Nikang Therapeutics Inc | Derivados de anillo tricíclico condensado como inhibidores de la fosfatasa de homología a src 2. |
US11014884B2 (en) | 2018-10-01 | 2021-05-25 | Global Blood Therapeutics, Inc. | Modulators of hemoglobin |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1752792A (en) | 1991-03-08 | 1992-10-06 | Rhone-Poulenc Rorer International (Holdings) Inc. | Multicyclic tertiary amine polyaromatic squalene synthetase inhibitors |
US5135935A (en) | 1991-05-17 | 1992-08-04 | Merck & Co., Inc. | Squalene synthetase inhibitors |
GB9127279D0 (en) * | 1991-12-23 | 1992-02-19 | Ici Plc | Heterocyclic derivatives |
JPH05310732A (ja) * | 1992-03-12 | 1993-11-22 | Mitsubishi Kasei Corp | シンノリン−3−カルボン酸誘導体 |
GB9207961D0 (en) * | 1992-04-10 | 1992-05-27 | Ici Plc | Heterocyclic derivatives |
GB9218334D0 (en) | 1992-08-28 | 1992-10-14 | Ici Plc | Heterocyclic compounds |
WO1995031458A1 (fr) | 1992-10-13 | 1995-11-23 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | 3-hydroxyquinuclidin-3-ylphenylquinolines en tant qu'inhibiteurs de la squalene synthase |
GB9226573D0 (en) * | 1992-12-21 | 1993-02-17 | Ici Plc | Heterocyclic compounds |
IL109451A0 (en) | 1993-04-29 | 1994-07-31 | Zeneca Ltd | Heterocyclic derivatives |
GB9412145D0 (en) * | 1994-06-17 | 1994-08-10 | Zeneca Ltd | Heterocycles |
JPH08134067A (ja) * | 1994-11-11 | 1996-05-28 | Yamanouchi Pharmaceut Co Ltd | キヌクリジン誘導体 |
JPH08269056A (ja) * | 1995-03-29 | 1996-10-15 | Chugai Pharmaceut Co Ltd | スクアレンシンセターゼ阻害作用を有するキヌクリジン誘導体 |
US5712270A (en) * | 1995-11-06 | 1998-01-27 | American Home Products Corporation | 2-arylamidothiazole derivatives with CNS activity |
JP2000511532A (ja) | 1996-05-20 | 2000-09-05 | メルク エンド カンパニー インコーポレーテッド | 性腺刺激ホルモン放出ホルモンのアンタゴニスト |
-
2000
- 2000-09-27 JP JP2001526535A patent/JP4206212B2/ja not_active Expired - Fee Related
- 2000-09-27 WO PCT/JP2000/006665 patent/WO2001023383A1/fr active IP Right Grant
- 2000-09-27 EP EP00962889A patent/EP1217001B1/fr not_active Expired - Lifetime
- 2000-09-27 DK DK00962889T patent/DK1217001T3/da active
- 2000-09-27 AU AU74464/00A patent/AU782114B2/en not_active Ceased
- 2000-09-27 CN CNB00813541XA patent/CN100334085C/zh not_active Expired - Fee Related
- 2000-09-27 ES ES00962889T patent/ES2252063T3/es not_active Expired - Lifetime
- 2000-09-27 BR BR0014331-6A patent/BR0014331A/pt not_active Application Discontinuation
- 2000-09-27 IL IL14863100A patent/IL148631A0/xx unknown
- 2000-09-27 US US10/088,554 patent/US6599917B1/en not_active Expired - Fee Related
- 2000-09-27 TW TW089119958A patent/TWI282794B/zh not_active IP Right Cessation
- 2000-09-27 NZ NZ517788A patent/NZ517788A/en not_active IP Right Cessation
- 2000-09-27 RU RU2002111344/04A patent/RU2266905C2/ru not_active IP Right Cessation
- 2000-09-27 KR KR1020027003952A patent/KR100694687B1/ko not_active IP Right Cessation
- 2000-09-27 CA CA002385995A patent/CA2385995C/fr not_active Expired - Fee Related
- 2000-09-27 MX MXPA02003167A patent/MXPA02003167A/es active IP Right Grant
- 2000-09-27 DE DE60024651T patent/DE60024651T2/de not_active Expired - Lifetime
- 2000-09-27 HU HU0203514A patent/HUP0203514A3/hu unknown
- 2000-09-27 AT AT00962889T patent/ATE312100T1/de not_active IP Right Cessation
-
2002
- 2002-03-12 IL IL148631A patent/IL148631A/en not_active IP Right Cessation
- 2002-03-26 NO NO20021528A patent/NO328218B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO20021528D0 (no) | 2002-03-26 |
TWI282794B (en) | 2007-06-21 |
NO20021528L (no) | 2002-05-28 |
HUP0203514A3 (en) | 2004-01-28 |
EP1217001A4 (fr) | 2002-12-18 |
WO2001023383A1 (fr) | 2001-04-05 |
ES2252063T3 (es) | 2006-05-16 |
RU2266905C2 (ru) | 2005-12-27 |
NO328218B1 (no) | 2010-01-11 |
CN1377349A (zh) | 2002-10-30 |
ATE312100T1 (de) | 2005-12-15 |
HUP0203514A2 (hu) | 2003-03-28 |
CN100334085C (zh) | 2007-08-29 |
IL148631A0 (en) | 2002-09-12 |
EP1217001B1 (fr) | 2005-12-07 |
CA2385995A1 (fr) | 2001-04-05 |
CA2385995C (fr) | 2009-06-16 |
EP1217001A1 (fr) | 2002-06-26 |
DE60024651T2 (de) | 2006-09-28 |
MXPA02003167A (es) | 2003-10-06 |
JP4206212B2 (ja) | 2009-01-07 |
KR20020034197A (ko) | 2002-05-08 |
DE60024651D1 (de) | 2006-01-12 |
US6599917B1 (en) | 2003-07-29 |
IL148631A (en) | 2010-04-29 |
KR100694687B1 (ko) | 2007-03-13 |
AU782114B2 (en) | 2005-07-07 |
AU7446400A (en) | 2001-04-30 |
BR0014331A (pt) | 2003-06-10 |
NZ517788A (en) | 2003-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1217001T3 (da) | Quinuclidinforbindelser og lægemidler indeholdende dem som den aktive bestanddel | |
NO20023457L (no) | Nye piperidinforbindelser og legemidler inneholdende de samme | |
PT976748E (pt) | Derivados de pirrolidina com actividade inibidora de fosfolipase a2 | |
CY1112130T1 (el) | Ενεργοποιητης για υποδοχεα δελτα αποκρινομενος σε πολλαπλασιαστη υπεροξειδιοσωματος | |
EA200200299A1 (ru) | НОВЫЕ α-АМИНОКИСЛОТНЫЕ СУЛЬФОНИЛЬНЫЕ СОЕДИНЕНИЯ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ ИХ СОДЕРЖАЩИЕ | |
AU8799201A (en) | Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases | |
ATE316089T1 (de) | Isoindolderivate | |
DE60223904D1 (de) | Benzylaminanalogen | |
AU2001269540A1 (en) | Serotonin reuptake inhibitors | |
EP1375496A4 (fr) | Derive d'amine cyclique a substitution n-aryle et medicament contenant ledit derive en tant que principe actif | |
BG105123A (en) | Tetrahydroquinaline derivatives as glycine antagonists | |
IL151880A0 (en) | Triazole derivatives and pharmaceutical compositions containing the same | |
DK0823254T3 (da) | Hidtil ukendt anvendelse af pyrazolopyridinforbindelser | |
WO2002024188A1 (fr) | Inhibiteur de la no synthetase inductible (inos) utilise pour le traitement ou la prevention de la myopie | |
TW200640887A (en) | PPAR-activating compound | |
MX2008002753A (es) | Derivados de piridazinona utilizados para el tratamiento de dolor. |